Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Oncology Reports
|
October 14, 1998
Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review)
J Kos, T T Lah
Biological Chemistry
|
April 2, 1998
Cysteine proteinases in cancer progression and their clinical relevance for prognosis
T T Lah, J Kos
The International Journal of Biological Markers
|
July 17, 2004
Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel
S Caserman, T T Lah
Phytotherapy Research : PTR
|
March 13, 2012
Xanthohumol induces different cytotoxicity and apoptotic pathways in malignant and normal astrocytes
I Zajc, M Filipič, T T Lah
Biological Chemistry Hoppe-Seyler
|
May 1, 1990
Cysteine proteinase inhibitors in human cancerous tissues and fluids
T T Lah, M Kokalj-Kunovar, V Turk
Neurosurgery
|
March 29, 2001
Cathepsins B and L are markers for clinically invasive types of meningiomas
T Strojnik, B Zidanik, J Kos, et al.
The International Journal of Biological Markers
|
April 19, 2005
Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas
M Trinkaus, A Vranic, V V Dolenc, et al.
Acta Neurochirurgica
|
September 25, 2003
Proteases in brain tumour progression
N Levicar, R K Nuttall, T T Lah, et al.
Journal of Periodontology
|
May 1, 1993
Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease
T T Lah, J Babnik, E Schiffmann, et al.
FEBS Letters
|
April 17, 1995
Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages
T T Lah, M Hawley, K L Rock, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Oncology Reports
|
October 14, 1998
Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review)
J Kos, T T Lah
Biological Chemistry
|
April 2, 1998
Cysteine proteinases in cancer progression and their clinical relevance for prognosis
T T Lah, J Kos
The International Journal of Biological Markers
|
July 17, 2004
Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel
S Caserman, T T Lah
Phytotherapy Research : PTR
|
March 13, 2012
Xanthohumol induces different cytotoxicity and apoptotic pathways in malignant and normal astrocytes
I Zajc, M Filipič, T T Lah
Biological Chemistry Hoppe-Seyler
|
May 1, 1990
Cysteine proteinase inhibitors in human cancerous tissues and fluids
T T Lah, M Kokalj-Kunovar, V Turk
Neurosurgery
|
March 29, 2001
Cathepsins B and L are markers for clinically invasive types of meningiomas
T Strojnik, B Zidanik, J Kos, et al.
The International Journal of Biological Markers
|
April 19, 2005
Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas
M Trinkaus, A Vranic, V V Dolenc, et al.
Acta Neurochirurgica
|
September 25, 2003
Proteases in brain tumour progression
N Levicar, R K Nuttall, T T Lah, et al.
Journal of Periodontology
|
May 1, 1993
Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease
T T Lah, J Babnik, E Schiffmann, et al.
FEBS Letters
|
April 17, 1995
Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages
T T Lah, M Hawley, K L Rock, et al.
Page
of 4